Birinapant and Carboplatin in Treating Patients and Targeting Recurrent High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (HGSOC)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0
- Status
- TERMINATED
- Phase
- PHASE2
Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Comparing SB8 and Avastin® in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
SCLC on the 2nd Line With Relapsed After Response to Chemotherapy GFPC 01-2013
- Status
- UNKNOWN
- Phase
- PHASE3
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemoradiotherapy in Elderly Patients With Oesophagus Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC
- Status
- RECRUITING
- Phase
- N/A
Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE1
Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)
- Status
- TERMINATED
- Phase
- PHASE2
Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)
- Status
- TERMINATED
- Phase
- PHASE3
Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2